Edmonton Obesity Staging System: an improvement by cardiopulmonary exercise testing.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
09 2021
Historique:
received: 26 10 2020
accepted: 30 04 2021
revised: 26 04 2021
pubmed: 16 5 2021
medline: 27 1 2022
entrez: 15 5 2021
Statut: ppublish

Résumé

Different approaches are used to classify obesity severity. Beyond classical anthropometric measurements, the Edmonton Obesity Staging System (EOSS) considers medical, physical and psychological parameters. However, this method has some limitations, principally due to the absence of an objective measure for physical impairment. The aim of our study is thus to overcome this limitation suggesting a new functional parameter obtained by cardiopulmonary exercise testing (CPET), i.e., cardiorespiratory fitness (CRF), expressed as weight-adjusted peak oxygen consumption (VO This observational cross-sectional study conducted on a population of 843 patients affected by obesity finally enrolled 500 subjects. Every patient underwent clinical, anthropometric, biochemical assessment and CPET. First, participants have been classified according to standard EOSS in five stages. Second, patients were reclassified according to the new modified EOSS (EOSS-CRF) based on their age- and gender-appropriate VO VO The integration of EOSS with CRF allowed us to assign to each patient a severity index that considers not only clinical parameters, but also their functional impairment through a quantitative and prognostically important parameter (VO

Sections du résumé

BACKGROUND/OBJECTIVES
Different approaches are used to classify obesity severity. Beyond classical anthropometric measurements, the Edmonton Obesity Staging System (EOSS) considers medical, physical and psychological parameters. However, this method has some limitations, principally due to the absence of an objective measure for physical impairment. The aim of our study is thus to overcome this limitation suggesting a new functional parameter obtained by cardiopulmonary exercise testing (CPET), i.e., cardiorespiratory fitness (CRF), expressed as weight-adjusted peak oxygen consumption (VO
SUBJECTS/METHODS
This observational cross-sectional study conducted on a population of 843 patients affected by obesity finally enrolled 500 subjects. Every patient underwent clinical, anthropometric, biochemical assessment and CPET. First, participants have been classified according to standard EOSS in five stages. Second, patients were reclassified according to the new modified EOSS (EOSS-CRF) based on their age- and gender-appropriate VO
RESULTS
VO
CONCLUSIONS
The integration of EOSS with CRF allowed us to assign to each patient a severity index that considers not only clinical parameters, but also their functional impairment through a quantitative and prognostically important parameter (VO

Identifiants

pubmed: 33990701
doi: 10.1038/s41366-021-00856-9
pii: 10.1038/s41366-021-00856-9
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1949-1957

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Global Burden of Disease Collaborative Network. Global burden of disease study 2015 (GBD 2015) obesity and overweight prevalence 1980–2015. Seattle, United States Institute for Health Metrics and Evaluation 2017.
Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18:715–23.
doi: 10.1111/obr.12551
Bhaskaran K, dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944–53.
doi: 10.1016/S2213-8587(18)30288-2
Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72:694–701.
doi: 10.1093/ajcn/72.3.694
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–20.
doi: 10.1056/NEJMoa0801891
Santini F, Busetto L, Cresci B, Sbraccia P. SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). Eat Weight Disord. 2016;21:305–7.
doi: 10.1007/s40519-016-0279-3
Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26:485–97.
Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33:289–95.
doi: 10.1038/ijo.2009.2
Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, et al. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011;36:570–6.
doi: 10.1139/h11-058
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183:1059–66.
doi: 10.1503/cmaj.110387
Ejima K, Xavier NA, Mehta T. Comparing the ability of two comprehensive clinical staging systems to predict mortality: EOSS and CMDS. Obesity. 2020;28:353–61.
doi: 10.1002/oby.22656
Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. JAMA. 1989;262:2395.
doi: 10.1001/jama.1989.03430170057028
Myers J, Prakash M, Froelicher V, Do D, Partington S, Edwin Atwood J. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.
doi: 10.1056/NEJMoa011858
Rabiee R, Agardh E, Kjellberg K, Falkstedt D. Low cardiorespiratory fitness in young adulthood and future risk of disability pension: A follow-up study until 59 years of age in Swedish men. J Epidemiol Community Health. 2015;69:266–71.
doi: 10.1136/jech-2014-204851
Ross R, Blair SN, Arena R, Church TS, Després JP, Franklin BA, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation. 2016;134:e653–99.
doi: 10.1161/CIR.0000000000000461
Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. European guidelines for obesity management in adults. Obes Facts. 2015;8:402–24.
doi: 10.1159/000442721
Bairaktari ET, Seferiadis KI, Elisaf MS. Evaluation of methods for the measurement of low-density lipoprotein cholesterol. J Cardiovasc Pharmacol Ther. 2005;10:45–54.
doi: 10.1177/107424840501000106
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323.
doi: 10.1093/eurheartj/ehz486
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
doi: 10.1007/BF00280883
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–81.
pubmed: 7154893
Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191–225.
doi: 10.1161/CIR.0b013e3181e52e69
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training. Circulation. 2013;128:873–934.
doi: 10.1161/CIR.0b013e31829b5b44
Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996;28:1567–72.
doi: 10.1016/S0735-1097(96)00412-3
Kaminsky LA, Arena R, Myers J. Reference standards for cardiorespiratory fitness measured with cardiopulmonary exercise testing data from the fitness registry and the importance of exercise national database. Mayo Clin Proc. 2015;90:1515–23.
doi: 10.1016/j.mayocp.2015.07.026
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 https://doi.org/10.1097/HJH.0b013e3281fc975a .
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–88.
doi: 10.1093/eurheartj/ehz455
Sateia MJ. International classification of sleep disorders-third edition. Chest. 2014;146:1387–94.
doi: 10.1378/chest.14-0970
Marchesini G, Day CP, Dufour JF, Canbay A, Nobili V, Ratziu V, et al. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Obes Facts. 2016;9:65–90.
doi: 10.1159/000443344
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57.
doi: 10.1002/hep.29367
Canning KL, Brown RE, Wharton S, Sharma AM, Kuk JL. Edmonton Obesity Staging System prevalence and association with weight loss in a publicly funded referral-based obesity clinic. J Obes. 2015;2015. https://doi.org/10.1155/2015/619734 .
Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261–74.
doi: 10.1161/CIR.0b013e31826fb946
Mehra MR, Jessup M, Gronda E, Costanzo MR. Rationale and process: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Hear Lung Transplant. 2006;25:1001–2.
doi: 10.1016/j.healun.2006.06.006
Malhotra R, Bakken K, D’Elia E, Lewis GD. Cardiopulmonary exercise testing in heart failure. JACC Hear Fail. 2016;4:607–16.
doi: 10.1016/j.jchf.2016.03.022
Swift DL, Lavie CJ, Johannsen NM, Arena R, Earnest CP, O’Keefe JH, et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J. 2013;77:281–92.
doi: 10.1253/circj.CJ-13-0007
Wasserman K, Hansen J, Sue D, Stringer W, Sietsema K, Sun X et al. Principles of exercise testing and interpretation. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
Weisman IM, Weisman IM, Marciniuk D, Martinez FJ, Sciurba F, Sue D, et al. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–77.
doi: 10.1164/ajrccm.167.10.952

Auteurs

Silvia Bettini (S)

Center for the Study and Integrated Treatment of Obesity (CeSTIO), Internal Medicine 3, Department of Medicine, University of Padova, Padova, Italy.

Giulia Quinto (G)

Sport and Exercise Medicine Division, Regional Center for the Therapeutic Prescription of Exercise in Chronic Disease, Department of Medicine, University of Padova, Padova, Italy. giulia.quinto9@gmail.com.

Daniel Neunhaeuserer (D)

Sport and Exercise Medicine Division, Regional Center for the Therapeutic Prescription of Exercise in Chronic Disease, Department of Medicine, University of Padova, Padova, Italy.

Francesca Battista (F)

Sport and Exercise Medicine Division, Regional Center for the Therapeutic Prescription of Exercise in Chronic Disease, Department of Medicine, University of Padova, Padova, Italy.

Anna Belligoli (A)

Center for the Study and Integrated Treatment of Obesity (CeSTIO), Internal Medicine 3, Department of Medicine, University of Padova, Padova, Italy.

Gabriella Milan (G)

Center for the Study and Integrated Treatment of Obesity (CeSTIO), Internal Medicine 3, Department of Medicine, University of Padova, Padova, Italy.

Andrea Gasperetti (A)

Sport and Exercise Medicine Division, Regional Center for the Therapeutic Prescription of Exercise in Chronic Disease, Department of Medicine, University of Padova, Padova, Italy.

Roberto Vettor (R)

Center for the Study and Integrated Treatment of Obesity (CeSTIO), Internal Medicine 3, Department of Medicine, University of Padova, Padova, Italy.

Andrea Ermolao (A)

Sport and Exercise Medicine Division, Regional Center for the Therapeutic Prescription of Exercise in Chronic Disease, Department of Medicine, University of Padova, Padova, Italy.

Luca Busetto (L)

Center for the Study and Integrated Treatment of Obesity (CeSTIO), Internal Medicine 3, Department of Medicine, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH